These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3013804)

  • 1. [False-positive results in the detection of anti-LAV/HTLV-III antibodies by enzyme immunoassay].
    Näher H; Tilgen W; Tilz G; Petzoldt D
    Hautarzt; 1986 Jun; 37(6):338-40. PubMed ID: 3013804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
    Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies reacting with the antigens of the human immunodeficiency virus in systemic lupus erythematosus].
    Nasonov EL; Aleksandrova LZ; Korneeva MN; Solov'ev SK; Nosik DN
    Ter Arkh; 1987; 59(7):40-2. PubMed ID: 3499678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus antibody screening in patients on renal replacement therapy: prevalence of false-positive results.
    Fassbinder W; Fürsch A; Kühnl P; Schoeppe W
    Nephrol Dial Transplant; 1987; 2(4):248-50. PubMed ID: 3118266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serology in HIV infection: comparison of indirect immunofluorescence, Western blot and enzyme immunoassay].
    Schmidt BL; Hutterer J; Kunz C; Gschnait F
    Wien Med Wochenschr; 1988 Apr; 138(8):174-80. PubMed ID: 3043921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
    Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
    AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Properties and transmission of the AIDS virus].
    Laufs R
    Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of EIA kits for the detection of HIV antibodies.
    Ovcak S; Drinovec B; Likar M
    Acta Virol; 1987 Sep; 31(5):434-8. PubMed ID: 2891282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of HTLV III screening tests in Christchurch.
    Field D; Whyte G; Robertson S
    N Z Med J; 1985 Nov; 98(791):992-3. PubMed ID: 3001606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
    Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K; Tebbe B; Finckh U; Rolfs A
    Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [False positive results of HIV virus tests in patients undergoing chronic hemodialysis].
    Ujhelyi E; Gál G; Makó J; Füst G; Büki B; Nagy K; Ferenc DT; Dietrich MP; Hengster P; Mayer V
    Orv Hetil; 1989 Jan; 130(2):67-70. PubMed ID: 2643779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of retroviral antibodies in the sera of patients with systemic lupus erythematosus.
    Fong KY; Boey ML; Yuen M; Nadarajah M; Feng PH
    Singapore Med J; 1996 Oct; 37(5):479-81. PubMed ID: 9046197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.